Stock listing
OTC:TRGNF Transgene SA Stock
US listing (OTC) of Transgene SA · home listing Euronext:TNG
Follow Transgene SA into a list and get an email when it puts out news.
Share price · OTC:TRGNF
$0.745 USD 0.000 (0.0%)
Close on Nov 6, 2026
- Day range
- $0.745 – $0.745 USDNov 6, 2026
- Market cap
- $259.1M USDAt the close on Nov 6, 2026 · price × 347.8M shares outstanding
- 52-week range
- $0.700 – $1.080 USDLowest and highest trades, Nov 7, 2025 – Nov 6, 2026
- Traded on an average day
- $20 USDMedian day 0 shares · 63 days with no trades · last 3 months, Aug 6, 2026 – Nov 6, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| Euronext:TNG · Home | €0.715 EUR | -0.006 (-0.8%) | 45,941 | €0.720 | €0.720 | €0.707 | €0.721 | Close on Nov 16, 2026 |
| LSE:0OCQ | €0.716 EUR | -0.004 (-0.6%) | 99 | €0.722 | €0.722 | €0.716 | €0.720 | Close on Nov 16, 2026 |
| OTC:TRGNF | $0.745 USD | 0.000 (0.0%) | — | $0.745 | $0.745 | $0.745 | $0.745 | Close on Nov 6, 2026 |
| Frankfurt:TGNA | €0.694 EUR | -0.012 (-1.7%) | — | €0.694 | €0.694 | €0.694 | €0.706 | Close on Nov 16, 2026 |
Daily closes
Last 3 months, Aug 6, 2026 – Nov 6, 2026 · OTC:TRGNF · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.745 | 0.000 | 0.0% | $0.745 | $0.745 | $0.745 | 0 | |
| $0.745 | 0.000 | 0.0% | $0.745 | $0.745 | $0.745 | 0 | |
| $0.745 | 0.000 | 0.0% | $0.745 | $0.745 | $0.745 | 0 | |
| $0.745 | 0.000 | 0.0% | $0.745 | $0.745 | $0.745 | 0 | |
| $0.745 | 0.000 | 0.0% | $0.745 | $0.745 | $0.745 | 0 | |
| $0.745 | 0.000 | 0.0% | $0.745 | $0.745 | $0.745 | 0 | |
| $0.745 | 0.000 | 0.0% | $0.745 | $0.745 | $0.745 | 0 | |
| $0.745 | 0.000 | 0.0% | $0.745 | $0.745 | $0.745 | 0 | |
| $0.745 | 0.000 | 0.0% | $0.745 | $0.745 | $0.745 | 0 | |
| $0.745 | -0.055 | -6.9% | $0.745 | $0.745 | $0.745 | 600 | |
| $0.800 | 0.000 | 0.0% | $0.800 | $0.800 | $0.800 | 0 | |
| $0.800 | 0.000 | 0.0% | $0.800 | $0.800 | $0.800 | 0 | |
| $0.800 | 0.000 | 0.0% | $0.800 | $0.800 | $0.800 | 0 | |
| $0.800 | 0.000 | 0.0% | $0.800 | $0.800 | $0.800 | 1,000 | |
| $0.800 | 0.000 | 0.0% | $0.800 | $0.800 | $0.800 | 0 | |
| $0.800 | 0.000 | 0.0% | $0.800 | $0.800 | $0.800 | 0 | |
| $0.800 | 0.000 | 0.0% | $0.800 | $0.800 | $0.800 | 0 | |
| $0.800 | 0.000 | 0.0% | $0.800 | $0.800 | $0.800 | 0 | |
| $0.800 | 0.000 | 0.0% | $0.800 | $0.800 | $0.800 | 0 | |
| $0.800 | 0.000 | 0.0% | $0.800 | $0.800 | $0.800 | 0 | |
| $0.800 | 0.000 | 0.0% | $0.800 | $0.800 | $0.800 | 0 | |
| $0.800 | 0.000 | 0.0% | $0.800 | $0.800 | $0.800 | 0 | |
| $0.800 | 0.000 | 0.0% | $0.800 | $0.800 | $0.800 | 0 | |
| $0.800 | 0.000 | 0.0% | $0.800 | $0.800 | $0.800 | 0 | |
| $0.800 | 0.000 | 0.0% | $0.800 | $0.800 | $0.800 | 0 | |
| $0.800 | 0.000 | 0.0% | $0.800 | $0.800 | $0.800 | 0 | |
| $0.800 | 0.000 | 0.0% | $0.800 | $0.800 | $0.800 | 0 | |
| $0.800 | 0.000 | 0.0% | $0.800 | $0.800 | $0.800 | 0 | |
| $0.800 | 0.000 | 0.0% | $0.800 | $0.800 | $0.800 | 0 | |
| $0.800 | 0.000 | 0.0% | $0.800 | $0.800 | $0.800 | 0 | |
| $0.800 | 0.000 | 0.0% | $0.800 | $0.800 | $0.800 | 0 | |
| $0.800 | 0.000 | 0.0% | $0.800 | $0.800 | $0.800 | 0 | |
| $0.800 | 0.000 | 0.0% | $0.800 | $0.800 | $0.800 | 0 | |
| $0.800 | 0.000 | 0.0% | $0.800 | $0.800 | $0.800 | 0 | |
| $0.800 | 0.000 | 0.0% | $0.800 | $0.800 | $0.800 | 0 | |
| $0.800 | 0.000 | 0.0% | $0.800 | $0.800 | $0.800 | 0 | |
| $0.800 | 0.000 | 0.0% | $0.800 | $0.800 | $0.800 | 0 | |
| $0.800 | 0.000 | 0.0% | $0.800 | $0.800 | $0.800 | 0 | |
| $0.800 | 0.000 | 0.0% | $0.800 | $0.800 | $0.800 | 0 | |
| $0.800 | 0.000 | 0.0% | $0.800 | $0.800 | $0.800 | 0 | |
| $0.800 | 0.000 | 0.0% | $0.800 | $0.800 | $0.800 | 0 | |
| $0.800 | 0.000 | 0.0% | $0.800 | $0.800 | $0.800 | 0 | |
| $0.800 | 0.000 | 0.0% | $0.800 | $0.800 | $0.800 | 0 | |
| $0.800 | 0.000 | 0.0% | $0.800 | $0.800 | $0.800 | 0 | |
| $0.800 | 0.000 | 0.0% | $0.800 | $0.800 | $0.800 | 0 | |
| $0.800 | 0.000 | 0.0% | $0.800 | $0.800 | $0.800 | 0 | |
| $0.800 | 0.000 | 0.0% | $0.800 | $0.800 | $0.800 | 0 | |
| $0.800 | 0.000 | 0.0% | $0.800 | $0.800 | $0.800 | 0 | |
| $0.800 | 0.000 | 0.0% | $0.800 | $0.800 | $0.800 | 0 | |
| $0.800 | 0.000 | 0.0% | $0.800 | $0.800 | $0.800 | 0 | |
| $0.800 | 0.000 | 0.0% | $0.800 | $0.800 | $0.800 | 0 | |
| $0.800 | 0.000 | 0.0% | $0.800 | $0.800 | $0.800 | 0 | |
| $0.800 | 0.000 | 0.0% | $0.800 | $0.800 | $0.800 | 0 | |
| $0.800 | 0.000 | 0.0% | $0.800 | $0.800 | $0.800 | 0 | |
| $0.800 | 0.000 | 0.0% | $0.800 | $0.800 | $0.800 | 0 | |
| $0.800 | 0.000 | 0.0% | $0.800 | $0.800 | $0.800 | 0 | |
| $0.800 | 0.000 | 0.0% | $0.800 | $0.800 | $0.800 | 0 | |
| $0.800 | 0.000 | 0.0% | $0.800 | $0.800 | $0.800 | 0 | |
| $0.800 | 0.000 | 0.0% | $0.800 | $0.800 | $0.800 | 0 | |
| $0.800 | -0.050 | -5.9% | $0.800 | $0.800 | $0.800 | 100 | |
| $0.850 | 0.000 | 0.0% | $0.850 | $0.850 | $0.850 | 0 | |
| $0.850 | 0.000 | 0.0% | $0.850 | $0.850 | $0.850 | 0 | |
| $0.850 | 0.000 | 0.0% | $0.850 | $0.850 | $0.850 | 0 | |
| $0.850 | 0.000 | 0.0% | $0.850 | $0.850 | $0.850 | 0 | |
| $0.850 | 0.000 | 0.0% | $0.850 | $0.850 | $0.850 | 0 | |
| $0.850 | 0.000 | 0.0% | $0.850 | $0.850 | $0.850 | 0 |
Splits
1 split · OTC:TRGNF · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 103-for-100 | Split |
- Ticker
- OTC:TRGNF
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- OTC
- Currency
- USD
What changed lately
Latest news release · Nov 9, 2026
Transgene Reports Continued Clinical Progress and Q3 2026 Financial Update
Latest earnings call · Mar 24, 2026
Transgene (Euronext:TNG) Q4 2025 Earnings Call
Replay and transcript
Latest deck · Sep 24, 2026
Investor Presentation (September 2026)
Investor deck · 43 slides
Calls
Replays
Transgene (Euronext:TNG) Q4 2025 Earnings Call
Tue, Mar 24, 2026 · 1:00 PM ET
Watch TranscriptTransgene (Euronext:TNG) Q2 2025 Earnings Call
Tue, Sep 16, 2025 · 12:00 PM ET
Watch Transcript
Latest news
First Patient Dosed in Phase 1 Trial Evaluating Transgene’s and BioInvent's BT-001 in Patients with Rectal Cancer
Nov 5, 2026
Closed $0.745 (0.0%) on Nov 5, 2026
Transgene to Present Preclinical Data on Novel Oncolytic Virus at SITC 2026 Supporting its Potential for Systemic Delivery
Nov 3, 2026
Closed $0.745 (0.0%) on Nov 3, 2026
Transgene Will Present a Poster on Preclinical Data from a Novel Oncolytic Virus at SITC 2026
Oct 5, 2026
Closed $0.80 (0.0%) on Oct 5, 2026
Transgene to Participate in Investor Access
Oct 1, 2026
Closed $0.80 (0.0%) on Oct 1, 2026
Transgene participera à l’Investor Access
Oct 1, 2026
Closed $0.80 (0.0%) on Oct 1, 2026
Transgene Extends its myvac® Platform, Further Establishing its Position as a Key Player in the Rapidly Emerging Individualized Cancer Immunotherapy Field
Sep 24, 2026
Closed $0.80 (0.0%) on Sep 24, 2026
Mise à disposition du Rapport Financier Semestriel au 30 juin 2026
Sep 23, 2026
Closed $0.80 (0.0%) on Sep 24, 2026
Transgene and ProBioGen Expand Strategic Partnership with Additional License Agreement for AGE1.CR.pIX Cell Line
Sep 8, 2026
Closed $0.80 (0.0%) on Sep 8, 2026
Financings
Private placement of new ordinary shares
Nov 25, 2025 · US$121.48M
Update: about €105M · Van Lanschot Kempen NV +1
Dealers: Van Lanschot Kempen NV (lead), Swiss Life Banque Privée (co-lead)
Buyers: TSGH (irrevocably committed to subscribe for at least €70 million); Dassault Group (SITAM Belgium) (with another existing shareholder, intends to participate for €10 million)
Use of proceeds: Accelerate the myvac individualized cancer vaccine program, R&D costs, and general and administrative expenses; cash runway to early 2028
Decks
Investor Presentation (September 2026)
Investor deck · 43 slides · Sep 24, 2026
World Congress on Infectious Diseases 2026
Conference · 30 slides · Jun 25, 2026
World Vaccine Congress, Washington D.C. 2026
Conference · 26 slides · Apr 1, 2026
FY2025 Earnings Presentation
Earnings · 18 slides · Mar 24, 2026
Transgene SA on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 36 in the last 12 months · 49 in all · newest Nov 9, 2026 · oldest 2025
- Calls
- 2 calls with a replay · 2 with a transcript · latest Mar 24, 2026
- Decks
- 66 decks · latest Sep 24, 2026
Where Transgene SA is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| Euronext:TNG · Home listing | Euronext | France | EUR |
| gettex:TGNA | gettex | Germany | EUR |
| LSE:0OCQ | LSE | United Kingdom | EUR |
| LS Exchange:913048 | LS Exchange | Germany | EUR |
| Lang & Schwarz:913048 | Lang & Schwarz | Germany | EUR |
| Munich:TGNA | Munich | Germany | EUR |
| OTC:TRGNF · This page | OTC | United States | USD |
| Frankfurt:TGNA | Frankfurt | Germany | EUR |
| Stuttgart:TGNA | Stuttgart | Germany | EUR |
| Aquis:TNGP | Aquis | United Kingdom | EUR |
| Aquis:TNGP | Aquis | United Kingdom | EUR |
| Dusseldorf:TGNA | Dusseldorf | Germany | EUR |
| Hamburg:TGNA | Hamburg | Germany | EUR |
| Turquoise:TNGP | Turquoise | United Kingdom | EUR |
Log in to ask 6ix AI your own questions about Transgene SA.